-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EMFdyFZUahUlcDCxKIW7AzMFfBPVBr7ITf954p3l+sTpaqRWEBI2mu86vf98LVJ/ Cil7ZhxUpBDsLaCv0KjKCg== 0000875320-08-000030.txt : 20080522 0000875320-08-000030.hdr.sgml : 20080522 20080522092822 ACCESSION NUMBER: 0000875320-08-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080520 FILED AS OF DATE: 20080522 DATE AS OF CHANGE: 20080522 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARRISON RICHARD C CENTRAL INDEX KEY: 0001256466 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 08853460 MAIL ADDRESS: STREET 1: 337 MARLBOROUGH STREET 3 CITY: BOSTON STATE: MA ZIP: 02115 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2008-05-20 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256466 GARRISON RICHARD C C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 0 1 0 0 SVP and Catalyst Common Stock 2008-05-20 4 S 0 74 27.48 D 29935 D Common Stock 2008-05-20 4 S 0 72 27.59 D 29863 D Common Stock 2008-05-20 4 S 0 146 27.61 D 29717 D Common Stock 2008-05-20 4 S 0 73 27.71 D 29644 D Common Stock 2008-05-20 4 S 0 73 27.47 D 29571 D Common Stock 2008-05-20 4 S 0 72 27.54 D 29499 D Common Stock 2008-05-20 4 S 0 72 27.64 D 29427 D Common Stock 2008-05-20 4 S 0 72 27.68 D 29355 D Common Stock 2008-05-20 4 S 0 73 27.94 D 29282 D Common Stock 799 I 401(k) Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Kenneth S. Boger, Attorney-In-Fact 2008-05-22 -----END PRIVACY-ENHANCED MESSAGE-----